PRNB - Principia Biopharma Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5785.04M
Enterprise Value 3615.48M
Trailing P/E N/A
Forward P/E 1-10.36
PEG Ratio (5 yr expected) 1-0.36
Price/Sales (ttm)9.83
Price/Book (mrq)4.60
Enterprise Value/Revenue 37.71
Enterprise Value/EBITDA 689.23

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 325.82%
S&P500 52-Week Change 32.62%
52 Week High 342.34
52 Week Low 322.00
50-Day Moving Average 336.49
200-Day Moving Average 334.22

Share Statistics

Avg Vol (3 month) 3140.28k
Avg Vol (10 day) 3144.85k
Shares Outstanding 523.97M
Float 11.76M
% Held by Insiders 113.92%
% Held by Institutions 195.64%
Shares Short (Aug 15, 2019) 4725.16k
Short Ratio (Aug 15, 2019) 48.78
Short % of Float (Aug 15, 2019) 46.15%
Short % of Shares Outstanding (Aug 15, 2019) 43.03%
Shares Short (prior month Jul 15, 2019) 4775.28k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 11.88%
Operating Margin (ttm)7.41%

Management Effectiveness

Return on Assets (ttm)3.29%
Return on Equity (ttm)11.79%

Income Statement

Revenue (ttm)79.86M
Revenue Per Share (ttm)4.15
Quarterly Revenue Growth (yoy)131.00%
Gross Profit (ttm)69.14M
EBITDA 6.9M
Net Income Avi to Common (ttm)-1.66M
Diluted EPS (ttm)-0.09
Quarterly Earnings Growth (yoy)295.90%

Balance Sheet

Total Cash (mrq)169.56M
Total Cash Per Share (mrq)7.07
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)12.77
Book Value Per Share (mrq)7.12

Cash Flow Statement

Operating Cash Flow (ttm)-1.94M
Levered Free Cash Flow (ttm)-6.68M